A key chapter in icometrix’s growth story was its win in the 28DIGITAL Champions competition in 2020 (known at the time as EIT Digital Champions). Back then, EIT Digital (which rebranded to 28DIGITAL this year) provided the startup with bespoke pan-European accelerator support—introductions to strategic partners, fundraising advice, and market-entry assistance.
Building on that momentum, icometrix raised over €18 million from investors like Capricorn Partners, HERAN Partners, Forestay Capital, and Optum Ventures. Those funds fuelled the maturation of icobrain, the company’s flagship platform that quantifies brain lesions and atrophy on MRI and CT scans, delivering objective metrics to radiologists and neurologists. The company cleared multiple regulatory hurdles and built a lightweight gateway—installable in as little as 15 minutes—to ensure seamless hospital integration.
The deal with GE HealthCare, expected to close in the first quarter of 2026 pending regulatory approval, is a perfect marriage of icometrix’s brain-disorder analytics and GE HealthCare’s commercial and regulatory heft.
Backed by GE HealthCare’s regulatory expertise and global reach, icometrix’s AI tools will become more widely available, helping to close gaps in neuro-diagnostic care. Clinicians will gain seamless access to quantitative imaging data—freeing them from routine measurements—while researchers benefit from robust imaging endpoints and real-world evidence for drug development.
In reflecting on icometrix’s impressive trajectory, 28DIGITAL’s Chief Innovation & Investments Officer Diva Tommei praised the team’s resilience and vision: “From retooling brain-imaging algorithms in five weeks to support COVID-19 patients, to pioneering quantitative neuro-diagnostics, icometrix embodies the resilient spirit of European deep-tech innovation. We’re delighted to see their decade of dedication rewarded with a partnership that will bring their life-changing solutions to clinicians and patients everywhere. Kudos to this incredible team!”
